Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration
- 1 July 1999
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 5 (7) , 753-759
- https://doi.org/10.1038/10473
Abstract
The inability to deliver growth factors locally in a transient but sustained manner is a substantial barrier to tissue regeneration. Systems capable of localized plasmid gene delivery for prolonged times may offer lower toxicity and should be well-suited for growth factor therapeutics. We investigated the potency of plasmid gene delivery from genes physically entrapped in a polymer matrix (gene activated matrix) using bone regeneration as the endpoint in vivo. Implantation of gene activated matrices at sites of bone injury was associated with retention and expression of plasmid DNA for at least 6 weeks, and with the induction of centimeters of normal new bone in a stable, reproducible, dose- and time-dependent manner.Keywords
This publication has 27 references indexed in Scilit:
- DNA delivery from polymer matrices for tissue engineeringNature Biotechnology, 1999
- Sustained Delivery of Proteins for Novel Therapeutic ProductsScience, 1998
- Gene therapyProceedings of the National Academy of Sciences, 1997
- Gene therapy - promises, problems and prospectsNature, 1997
- Stimulation of new bone formation by direct transfer of osteogenic plasmid genes.Proceedings of the National Academy of Sciences, 1996
- Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human PrimatesHuman Gene Therapy, 1995
- Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in MiceHuman Gene Therapy, 1995
- Tissue EngineeringScience, 1993
- Pathology of Recombinant Human Transforming Growth Factor-β1 in Rats and RabbitsPublished by Elsevier ,1993
- Bone: Formation by AutoinductionScience, 1965